Tag Archives: stage IV colorectal cancer

DIANA-SCOTT-WE-STILL-DO

We Still Do – Diana & Scott Welch

We Still Do – Diana & Scott Welch

MEET DIANA & SCOTT WELCH  DIANA’S PERSPECTIVE They say that life crises can sometimes either make or break a marriage or relationship.  My cancer diagnosis (or better said as our cancer diagnosis) has done just that.  Facing this challenge has made our bond stronger, our love deeper, and our compassion more profound. Scott and I were reunited in December 1999 after I sent him a Christmas card as we lived in different states.  We corresponded back and forth for several months and he made several visits to Upstate New York where I had lived at that time (and we are both originally from).  Although the long distance thing was exciting,

Meet the One Million Strong – Deborah Anders from Texas

Be a part of One Million Strong and tell us how colorectal cancer has impacted your life! Share your story now!  MEET DEBORAH Deborah Anders, Survivor From Austin, TX DEBORAH’S STORY I am a stage IV colorectal cancer survivor going on 6 years this May. I have been through fours kinds of chemotherapy and  seven surgeries.  I lost my dad 31 years ago and  my mother four months before me to lung and brain cancer. I have four grown kids that need to learn more about colorectal cancer and being tested. DEBORAH’S ADVICE Surround yourself with positive, loving support groups and educate yourself. This is not an old persons disease. WHAT

WEAR-BLUE-FOR-MOM

Meet the One Million Strong – Natia Porter from New York

Be a part of One Million Strong and tell us how colorectal cancer has impacted your life! Share your story now!  MEET NATIA Natia Porter, Family New York, NY NATIA’S STORY Lynch syndrome or (wrongly called) non-polyposis colorectal cancer runs in genes from my mother’s side. It is wrongly called because it predisposes us up to 8 different types of cancers on a different degree. The first, the almost 99% predisposition is to colon caners, then uterus cancer, renal cancer, ovarian, brain and so on.  In my family, as I later discovered, there has been many colon cancers, many uterus cancers, some renal and one-brain cancer cases. However, I did not

crc-survivor-march

Meet the One Million Strong – Brian Greenlaw from Rhode Island

Be a part of One Million Strong and tell us how colorectal cancer has impacted your life! Share your story now!  MEET BRIAN Brian Greenlaw, Survivor Warwick RI BRIAN’S STORY I was diagnosed April 1, 2013 at age 43 with stage IV colorectal cancer which spread to both sides of my liver. I have had 14 rounds of chemo, 30 radiation treatments and two liver resection surgeries. I am now cancer free currently and feeling well!! My advice is believe in God, your medical team, and always be positive. Live your life as you did prior to your diagnosis, get back to your routine, work, exercise etc… Also have a spiritual

jointhemovement-one-million-strong-fight-crc

Meet the One Million Strong – Mandy C. from Alabama

Be a part of One Million Strong and tell us how colorectal cancer has impacted your life! Share your story now!  MEET MANDY  Mandy Carroll, Survivor From West Blocton, Alabama MANDY’S STORY I was diagnosed at 26 years old with stage IIIA colon cancer in 2009. I have been diagnosed since then with stage IV because it spread. I have gone through 24 rounds of chemotherapy to date and still have a long way to go, but I am a survivor and I will stay that way! I have a Facebook page called Mandy’s Fighters if you would like to follow my fight. I have been blessed with two beautiful daughters

Fight Colorectal Cancer Awards Late Stage Disease Research Grant

Fight Colorectal Cancer and its generous Lisa Fund donors struck a blow against late stage colorectal cancer Tuesday, April 9th at the 2013 annual meeting of the American Association for Cancer Research (AACR) in Washington D.C. Top cancer researchers from around the nation applauded as we, along with the AACR, awarded a $50,000 research grant to Pia Morelli, M.D., Ph.D., a post-doctoral Fellow at the University of Texas MD Anderson Cancer Center in Houston. With this grant, Dr. Morelli will use highly specific DNA tests on blood samples to identify those patients most likely to respond to drugs that target the Epidermal Growth Factor Receptor (EGFR), and also to detect

GRATITUDE FOR YOUR GENEROSITY: Our First Two-Year Research Grant

by Mary Miller Fight Colorectal Cancer is thrilled to announce during this holiday season that thanks to the generous donations made to the Lisa Fund, it will be awarding its first-ever two-year $100,000 grant to a scientist whose work fights advanced stage colorectal cancer. Andrea Bertotti, MD, PhD, of the Institute for Cancer Research and Treatment (IRCC) in Candiolo, Italy, has learned that his lab will receive this major grant. “His work will be ground-breaking and exactly in line with the reason Lisa Dubow created this fund—to support a promising researcher working to advance the treatment of metastatic colorectal cancer,” said Carlea Bauman, president of Fight Colorectal Cancer. Fully 100

FDA Approves Regorafenib for Metastatic CRC

  The FDA today approved the use of the drug regorafenib (brand name Stivarga) for patients whose metastatic colorectal cancer has progressed despite all currently approved treatment regimens. This is the second new drug approved by the FDA recently after a drought of 5 years in approving new treatments for metastatic colorectal cancer (mCRC). Regorafenib was placed into the  FDA’s “fast-track” approval process after the international, multicenter Phase III CORRECT trial  showed improved survival (from 5 to 6.4 months) in all mCRC patients, including those having both non-mutated and mutated KRAS types.

Patients with metastatic CRC may not need removal of asymptomatic colon tumor

Despite better screening for colorectal cancer (CRC), about 1 in 5 newly diagnosed patients will have metastatic CRC that already has spread to distant organs.  Many will have symptoms of fatigue or weight loss, but only a minority will have symptoms (significant bleeding or abdominal pain, or a blocked bowel) caused by the colon tumor itself. In those people first diagnosed with stage IV CRC, about 80% have metastases that cannot be removed by surgery. There’s been intense debate—but no clear evidence—about whether patients whose colon tumor isn’t causing symptoms should have the colon tumor surgically removed routinely before they start chemotherapy.  A recent important study provides the first evidence

X-PECT Trial is Fully Enrolled

The X-PECT phase III clinical trial has finished recruiting over 430 patients, evaluating perifosine treatment for patients with advanced colorectal cancer who have exhausted standard treatments. The trial compares the effectiveness of adding perifosine to Xeloda® (capecitabine). Led by Johanna Bendell, M.D., from the Sarah Cannon Research Institute in Nashville, TN, the trial is being conducted at 65 sites in the United States.

Top